Abstract
Firm value is the consequence of a company's performance, as represented in its share price, which is determined by the relationship between supply and demand in the stock market. The aim is to test and assess the impact of capital structure (DER) and profitability (ROA) on Firm value (PBV) in pharmaceutical firms listed on the Indonesia Stock Exchange (BEI) between 2017 and 2021. Purposive sampling is used to establish sampling. Ten pharmaceutical businesses serve as the research population. During a 5-year observation period, 40 samples were chosen from 8 firms based on the specified criteria. The analytical approach used in this study is multiple linear regression. The data analysis test tool runs the IBM SPSS version 26.0 program on Windows. The findings of this study reveal that capital structure has a significant influence (sig. 0.000) on firm value as well as profitability (sig. 0.022).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
